Matt Norton - Co-Creating, Partnering, and Licensing DTx

Co-creating, partnering, and licensing DTx: The trade-offs for pharma on responsibilities, risk, and retaining commercial control

Matt Norton - Co-Creating, Partnering, and Licensing DTx

Matt Norton, VP of Marketing & Commercial Development, talks about Co-creating, partnering, and licensing DTx: The trade-offs for pharma on responsibilities, risk, and retaining commercial control:

  • What are the trade-offs and potential downsides
  • What is the right mix to build success: responsibilities, risk, and commercial control
  • Our experience and learnings from the co-creation of DTx
BACK TO Videos

Contact one of our experts to discuss your needs and we’ll find the right solution for you.

Contact Us